E
AquaBounty Technologies, Inc. AQB
$0.93 -$0.02-1.86% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

AquaBounty Technologies, Inc. is a U.S.-based biotechnology and aquaculture company focused on the production of genetically engineered Atlantic salmon for human consumption. The company operates within the aquaculture, biotechnology, and food production industries, with its core value proposition centered on producing salmon that grow faster and can be farmed in land-based, controlled environments. AquaBounty’s primary revenue driver is the commercial sale of salmon produced from its proprietary AquAdvantage® Salmon technology.

The company’s key customers are seafood distributors, foodservice operators, and retail channels primarily in North America. AquaBounty is uniquely positioned as the first company to receive U.S. regulatory approval for genetically engineered animal protein for food use, supported by extensive regulatory review and intellectual property protections. Founded in 1991, the company initially focused on genetic research in aquatic species and later transitioned toward commercial-scale aquaculture, culminating in U.S. Food and Drug Administration approval of AquAdvantage® Salmon in 2015 and subsequent commercial harvests in the early 2020s.

Business Operations

AquaBounty operates as a vertically integrated aquaculture company, overseeing broodstock development, egg production, grow-out farming, and harvest. Its operations are organized around a single primary business segment focused on land-based salmon farming using recirculating aquaculture systems (RAS). Revenue is generated through the sale of harvested salmon and, to a lesser extent, the sale of salmon eggs to authorized facilities.

The company’s operational assets include its broodstock and egg production facility in Canada, as well as grow-out farms in Indiana and other U.S. locations. AquaBounty controls proprietary genetic technology, biosecure farming systems, and specialized aquaculture processes designed to reduce disease risk and environmental impact. Its principal subsidiaries include AquaBounty Farms Indiana LLC and AquaBounty Canada Inc., which manage regional operations and assets.

Strategic Position & Investments

AquaBounty’s strategic direction is focused on scaling commercial production, improving unit economics, and expanding land-based aquaculture capacity closer to end markets. Growth initiatives have historically included investment in new RAS facilities, optimization of feed conversion and survival rates, and selective expansion of farming capacity in the United States. The company positions its technology as a solution to global seafood demand, sustainability concerns, and supply chain constraints affecting wild-caught salmon.

The company has made significant capital investments in its Indiana farm and previously pursued expansion projects in Ohio and other regions, although some projects have been delayed, modified, or reassessed based on capital availability and market conditions. AquaBounty’s technology portfolio remains concentrated on AquAdvantage® Salmon, with no publicly verified diversification into other species as of the most recent disclosures. Data inconclusive based on available public sources regarding near-term large-scale acquisitions or joint ventures.

Geographic Footprint

AquaBounty’s headquarters are located in Massachusetts, United States, with operational facilities spanning North America. Its core production footprint includes land-based aquaculture farms in the Midwestern United States and broodstock and egg production operations in Prince Edward Island, Canada. These locations support biosecure production and proximity to major North American seafood markets.

While the company’s commercial sales and operations are currently concentrated in the United States and Canada, its regulatory approvals and intellectual property give it potential access to other international markets. However, there is no verified evidence of active commercial operations outside North America as of the latest publicly available filings.

Leadership & Governance

AquaBounty is led by an executive team with experience in biotechnology, food production, and regulated industries. The leadership emphasizes operational discipline, regulatory compliance, and sustainable protein production through innovation in aquaculture systems.

Key executives include:

  • Sylvia WulfPresident and Chief Executive Officer
  • David FrankChief Financial Officer
  • John CurtisVice President of Operations
  • Matt L. TarrantGeneral Counsel and Corporate Secretary

The company is governed by a board of directors responsible for oversight of strategy, risk management, and compliance with public company obligations, as disclosed in its SEC filings.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $173.53
B
AAPL NASDAQ $254.63
B
AVGO NASDAQ $312.34
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $122.80
B
Top Financial Stocks
See All »
B
B
JPM NYSE $291.72
B
V NYSE $304.68
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.82
Top Health Care Stocks
See All »
B
LLY NYSE $905.29
B
JNJ NYSE $241.35
B
AMGN NASDAQ $352.37
Top Real Estate Stocks
See All »
B
PLD NYSE $129.89